Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04319003 · ClinicalTrials.gov registry record · NA

Pilot Sugar Reduction Intervention in Kiritimati Teenagers

A NA study, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
63
Enrollment target

NCT04319003 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 63 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04319003, a NA study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target

Study Summary

Kiritimati is an isolated coral atoll in the Pacific Ocean, and is one of 32 islands that comprise the Republic of Kiribati. Obesity and type 2 diabetes rates are high in Kiribati, but the causes and rates of childhood obesity/diabetes are unknown. However, it has been hypothesized that high consumption of sugar-sweetened beverages on Kiritimati may be a contributing factor. The investigators therefore conducted a study in Kiritimati in September 2018 with the aim of 1) quantifying obesity and diabetes rates amongst children on Kiritimati and 2) testing the feasibility of a sugar-reduction intervention in Kiritimati schools. The investigators randomized the two high schools on the island to either the control group or the intervention group. The investigators measured height/weight, continuous blood glucose (using flash glucose monitoring), and diet (using 24-hour diet recalls). One week into the study, the intervention school received an intervention, which consisted of installation of a water filter at the school, the provision of water bottles to each student at the school, and a 30-minute educational presentation on the link between sugar consumption and type 2 diabetes. The investigators then measured how blood glucose and diet changed the week following the intervention, and compared this to the control school.

Interventions

  • BEHAVIORAL Sugar-reduction intervention

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2018-08-03
Est. Completion 2018-09-19
Phase NA

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT04319003

The ClinicalTrials.gov registry entry for NCT04319003 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Sugar-reduction intervention is the first listed.

NCT04319003 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04319003 about?

NCT04319003 is a clinical study titled "Pilot Sugar Reduction Intervention in Kiritimati Teenagers". Kiritimati is an isolated coral atoll in the Pacific Ocean, and is one of 32 islands that comprise the Republic of Kiribati. Obesity and type 2 diabetes rates are high in Kiribati, but the causes and rates of childhood obesity/diabetes are unknown. However, it has been hypothesized that high consump...

What is the current status of trial NCT04319003?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2018-08-03. Estimated completion is 2018-09-19.

What interventions are being tested in trial NCT04319003?

The interventions under investigation include: Sugar-reduction intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04319003?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.